Scholar Rock Holding Corp. (SRRK)
57.80
-1.46
(-2.46%)
USD |
NASDAQ |
Aug 28, 16:00
57.85
+0.05
(+0.09%)
After-Hours: 20:00
Scholar Rock Net Income (Quarterly) : -109.90M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -109.90M |
| March 31, 2026 | -105.51M |
| December 31, 2025 | -90.96M |
| September 30, 2025 | -102.22M |
| June 30, 2025 | -110.03M |
| March 31, 2025 | -74.72M |
| December 31, 2024 | -66.45M |
| September 30, 2024 | -64.48M |
| June 30, 2024 | -58.51M |
| March 31, 2024 | -56.85M |
| December 31, 2023 | -46.13M |
| September 30, 2023 | -42.36M |
| June 30, 2023 | -37.92M |
| March 31, 2023 | -39.38M |
| December 31, 2022 | -39.26M |
| September 30, 2022 | -43.30M |
| June 30, 2022 | -44.00M |
| March 31, 2022 | -7.95M |
| December 31, 2021 | -35.91M |
| Date | Value |
|---|---|
| September 30, 2021 | -37.51M |
| June 30, 2021 | -30.71M |
| March 31, 2021 | -27.67M |
| December 31, 2020 | -26.57M |
| September 30, 2020 | -23.56M |
| June 30, 2020 | -19.28M |
| March 31, 2020 | -17.07M |
| December 31, 2019 | -11.57M |
| September 30, 2019 | -16.15M |
| June 30, 2019 | -12.52M |
| March 31, 2019 | -10.76M |
| December 31, 2018 | -14.97M |
| September 30, 2018 | -10.76M |
| June 30, 2018 | -14.71M |
| March 31, 2018 | -8.892M |
| December 31, 2017 | -8.457M |
| September 30, 2017 | -5.929M |
| June 30, 2017 | -5.879M |
| March 31, 2017 | -4.73M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 109.90M |
| EPS Diluted (Quarterly) | -0.8414 |
| Enterprise Value | 6.740B |
| Earnings Yield | -5.97% |
| Normalized Earnings Yield | -5.940 |